Predictors of survival among older adults with ependymoma
- PMID: 21952907
- PMCID: PMC3863332
- DOI: 10.1007/s11060-011-0730-2
Predictors of survival among older adults with ependymoma
Abstract
The biological process of aging encompasses a multitude of complex physiological and lifestyle changes that may alter the way typical prognostic factors affect survival among older ependymoma patients. Because very little is known about the clinical significance of traditional prognostic factors and the magnitude of their effects among older individuals, the purpose of this study was to evaluate the associations between survival and demographic and tumor characteristics among patients with ependymoma who were 60 years of age or older. Using the 1973-2007 dataset from the Surveillance, Epidemiology and End Results (SEER) program, we evaluated the impact of several factors on both overall and ependymoma-specific survival, utilizing multivariable Cox proportional hazards regression. We identified 367 ependymoma cases who were 60 years of age or older at diagnosis and had complete data from SEER. Of these, 19 (5.2%) had anaplastic tumors; all others were low-grade tumors. Age, tumor site, extent of surgery, and tumor histology were found to be significant predictors of ependymoma prognosis. The strongest predictor of poor outcome was supratentorial tumor location (adjusted HR: 6.94, 95% CI: 3.19-15.08, compared to spinal cord tumors). Our study suggests that tumor location, tumor histology, and surgical margin may be key predictors of survival among older ependymoma patients. We believe our study is one of the first to assess the prognostic value of these factors for ependymoma survival exclusively in an older patient population.
Conflict of interest statement
Figures
References
-
- Miller RA. Gerontology as oncology. Research on aging as the key to the understanding of cancer. Cancer. 1991;68(11 Suppl):2496–2501. - PubMed
-
- Rowland JH, Yancik R. Cancer survivorship: the interface of aging, comorbidity, and quality care. J Natl Cancer Inst. 2006;98(8):504–505. - PubMed
-
- Miller RA. Aging and immune function. Int Rev Cytol. 1991;124:187–215. - PubMed
-
- Bureau USC General Demographic Characteristics. [Accessed January 25, 2011];Population Estimates. 2008 http://factfinder2.census.gov/faces/nav/jsf/pages/index.xhtml.
-
- Avis NE, Deimling GT. Cancer survivorship and aging. Cancer. 2008;113(12 Suppl):3519–3529. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
